The trajectory of copyright's flagship drug presents a complex case for observers in the medicinal sector. While initially a tremendous success, producing vast sums, the intellectual property end and the subsequent arrival of off-brand competitors have considerably affected income. This presents questions about the future viability of related dr… Read More